No differences were found between SGLT2-i users and non-SGLT2-i users in the occurrence of electrolyte imbalances; no differences in potassium, calcium, and magnesium concentrations that could potentially impact the onset of arrhythmias. This evidence concerns the gene SLC5A2 and cardiac arrhythmia.